Intracellular lipid content of liver and skeletal muscle in patients with adult growth hormone deficiency without diabetes mellitus

Obesity Research and Clinical Practice

Volumn 6, Issue 4, 2012, Pages

  Sato, Tomoko ^a   Katabami, Takuyuki ^a   Furukawa, Kentaro ^a   Narimatsu, Hiroshi ^b   Hashimoto, Takuo ^a   Nakajima, Yasuo ^a   Ohta, Akio ^a   Sasaoka, Toshiyasu ^c   Tanaka, Yasushi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE HOSPITAL   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Adult growth hormone deficiency; Insulin resistance; Intrahepatic lipid; Proton magnetic resonance spectroscopy

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; ADULT GROWTH HORMONE DEFICIENCY; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAMYOCELLULAR LIPID LEVEL; LIPID LIVER LEVEL; MALE; METABOLIC SYNDROME X; MUSCLE LEVEL; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84868205675     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2011.09.001     Document Type: Article

References (40)

1. A. Gastaldelli, Y. Miyazaki, M. Pettiti, M. Matsuda, S. Mahankali, and E. Santini Metabolic effects of visceral fat accumulation in type 2 diabetes J Clin Endocrinol Metab 87 2002 5098 5103
2. G.L. Vega, B. Adamas-Huet, R. Peshock, D. Willett, B. Shah, and S.M. Grundy Influence of body fat content and distribution on variation in metabolic risk J Clin Endocrinol Metab 91 2006 4459 4466
3. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375
4. Y. Tamura, Y. Tanaka, F. Sato, J.B. Choi, H. Watada, and M. Niwa Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients J Clin Endocrinol Metab 90 2005 3191 3196
5. F. Sato, Y. Tamura, H. Watada, N. Kumashiro, Y. Igarashi, and H. Uchino Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects J Clin Endocrinol Metab 92 2007 3326 3329
6. K. Furukawa, T. Katabami, Y. Nakajima, T. Sato, H. Kato, and R. Koganei Evaluation of whole-abdominal fat volume by 700-slice CT scanning and comparison with the umbilical fat area anthropometric indices Obes Res Clin Pract 4 2010 e111 e117
7. Y. Sada, Y. Katabami, S. Asai, T. Sato, K. Furukawa, and S. Ishii Intrahepatic lipid content is linked to insulin resistance in obese subjects Obes Res Clin Pract 5 2011 e129 e136
8. H. Mersebach, and U. Feldt-Rasmussen Growth hormone and body composition J.O.L. Jorgensen, J.S. Christiansen, Growth hormone deficiency in adults Front Horm Res 33 2005 185 195
9. J.O. Jorgensen, S.A. Pedersen, L. Thuesen, J. Jorgensen, T. Ingemann-Hansen, and N.E. Skakkebaek Beneficial effects of growth hormone treatment in GH-deficient adults Lancet 122 1989 1 1225
10. A.A. van der Klaauw, N.R. Biermasz, E.J. Feskens, M.B. Bos, J.W. Smit, and F. Roelfsema The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH Eur J Endocrinol 156 2007 455 462
11. F. Salomon, R.C. Cuneo, R. Hesp, and P.H. Sönksen The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency N Engl J Med 321 1989 1797 1803
12. K. Chihara, A. Shimatsu, Y. Kato, H. Kohno, T. Tanaka, and K. Takano Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phase Endocr J 53 2006 853 858
13. Y. Takahashi, K. Iida, K. Takahashi, S. Yoshioka, H. Fukuoka, and R. Takeno Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency Gastroenterology 132 2007 938 943
14. G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, and L. Zenari Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients Diabetes Care 30 2007 1212 1218
15. L.S. Szczepaniak, E.E. Babcock, F. Schick, R.L. Dobbins, A. Garg, and D.K. Burns Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo Am J Physiol 276 1999 E977 E989
16. S.W. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679
17. 1H long echo time spectra at 1.5 and 3 T by means of the LC-Model technique J Magn Reson Imaging 23 2006 728 735
18. 1H-MR spectroscopy Radiology 236 2005 609 614
19. C.E. Tan, S. Ma, D. Wai, S.K. Chew, and E.S. Tai Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diabetes Care 27 2004 1182 1186
20. T. Ichikawa, K. Hamasaki, H. Ishikawa, E. Ejima, K. Eguchi, and K. Nakao Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency Gut 52 2003 914
21. J.W. Hong, J.Y. Kim, Y.E. Kim, and E.J. Lee Metabolic parameters and nonalcoholic fatty liver disease hypopituitary men Horm Metab Res 43 2011 48 54
22. A. Vijayakurmar, R. Novosyadlyy, Y. Wu, S. Yakar, and D. LeRoith Biological effects of growth hormone on carbohydrate and lipid metabolism Growth Horm IGF Res 20 2010 1 7
23. Z. Wang, M.M. Masternak, K.A. Al-Regaiey, and A. Bartke Adipocytokines and the regulation of lipid metabolism in GH transgenic and calorie-restricted mice Endocrinology 148 2007 2845 2853
24. L.A. Adams, A. Feldstein, K.D. lindor, and P. Angulo NAFLD among patients with hypothalamic and pituitary dysfunction Hepatology 39 2004 909 914
25. I. Fukuda, N. Hizuka, K. Yasumoto, J. Morita, M. Kurimoto, and K. Takano Metabolic co-morbidities revealed in patients with childhood-onset adult GH-deficiency after cessation of GH replacement Endocr J 55 2008 977 984
26. J.L. Barkley, N.N. Nelson, M. Ishikawa, L.A. Murray, L.M. Kerr, and T.R. McPhee GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism Endocrinology 152 2011 181 192
27. P. Loria, L. Carulli, M. Bertolotti, and A. Lonardo Endocrine and liver interaction: the role of endocrine pathways in NASH Nat Rev Gastroenterol Hepatol 6 2009 236 247
28. H. Völzke, M. Nauck, R. Rettig, M. Dörr, C. Higham, and G. Brabant Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample Eur J Endocrinol 161 2009 705 713
29. H. Norrelund, C.H. Gravholt, P. Englaro, W.F. Blum, W. Rascher, and J.S. Chistiansen Increased levels but preserved diurnal variation of serum leptin in GH-deficient patients: lack of impact of different models of GH administration Eur J Endocrinol 46 1998 812 817
30. P. Angulo, L.M. Alba, L.M. Petrovic, L.A. Adams, K.D. Lindor, and M.D. Jensen Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease Hepatology 41 2004 943 949
31. N. Ozbey, E. Algun, A.S. Turgut, Y. Orhan, E. Sencer, and S. Molvalilar Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency Int J Obes Relat Metab Disord 24 2000 619 626
32. L. Ibáñez, A. López-Bermejo, M. Díaz, M.V. Marcos, P. Casano, and F. de Zegher Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age J Clin Endocrinol Metab 94 2009 1049 1052
33. C. Joaquin, E. Aguilera, M.L. Granada, M.C. Pastor, I. Salinas, and N. Alonso Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A Eur J Endocrinol 158 2008 483 490
34. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
35. V.T. Samuel, Z.X. Liu, A. Wang, S.A. Beddow, J.G. Geisler, and M. Kahn Inhibition of protein kinase C epsilon prevents hepatic insulin resistance in non-alcoholic fatty liver disease J Clin Invest 117 2007 739 745
36. M.B. Krag, L.C. Gormsen, X. Guo, J.S. Christiansen, M.D. Jensen, and S. Nielsen Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics Am J Physiol 292 2007 E920 E927
37. R. Trepp, M. Flck, C. Stettler, C. Boesch, M. Ith, and R. Kreis Effect of GH on human skeletal muscle lipid metabolism in GH deficiency Am J Physiol 294 2008 E1127 E1134
38. Y. Tamura, H. Watada, Y. Igarashi, T. Nomiyama, T. Onishi, and K. Takahashi Short-term effects of dietary fat on intramyocellular lipid in sprinters and endurance runners Metabolism 57 2008 373 379
39. Y. Gutierrez-Grobe, G. Ponciano-Rodríguez, M.H. Ramos, M. Uribe, and N. Méndez-Sánchez Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens Ann Hepatol 9 2010 402 429
40. M. Akhondi-Meybodi, M.R. Mortazavy-Zadah, Z. Hashemian, and M. Moaiedi Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer Arab J Gastroenterol 12 2011 34 36